Abstract

With many biotech companies reaching for commercial success, it helps when the founding science comes from an unquestioned leader in the field. Such is the case with Ancora Pharmaceuticals (http://www.ancorapharma.com), founded in 2003 to develop a synthetic carbohydrate platform based on work licensed from MIT. In 2002, the company's scientific cofounder, Dr. Peter Seeberger, a world-class carbohydrate chemist then based at MIT, helped establish the company after winning an MIT-based entrepreneurial competition, setting in motion the foundation for the now 20 person company based in Medford, Massachusetts.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.